Brief: ADMA Biologics Enters Into A Manufacturing And Supply Agreement To Produce And Sell Plasma-Derived Intermediate Fractions

ADMA Biologics

07/01/2020 12:40

Jan 7 (Reuters) - ADMA Biologics Inc  ADMA.O :
    * ADMA BIOLOGICS ENTERS INTO A MANUFACTURING AND SUPPLY
AGREEMENT
TO PRODUCE AND SELL PLASMA-DERIVED INTERMEDIATE FRACTIONS
    * ADMA BIOLOGICS - AGREEMENT IS EXPECTED TO ADD $5-10
MILLION IN
ANNUAL REVENUES FOR 2020 AND 2021
    * ADMA BIOLOGICS - AGREEMENT IS EXPECTED TO ADD $10-20
MILLION PER
YEAR FOR 2022 THROUGH 2024
    * ADMA BIOLOGICS - ANNOUNCED ENTRY INTO 5-YEAR MANUFACTURING
AND
SUPPLY AGREEMENT WITH AN UNDISCLOSED PARTNER
    * ADMA BIOLOGICS - BELIEVE THIS CONTRACT HAS POTENTIAL TO
GENERATE
BETWEEN $10 MILLION & $20 MILLION PER YEAR FROM 2022 THROUGH
2024

Source text for Eikon:  ID:nGNX16wBCv 
Further company coverage:  ADMA.O 

 (((Reuters.Briefs@thomsonreuters.com);))